APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor VIIa

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Coagulation Factor VIIa Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchCoagulation Factor VIIa Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor VIIa Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Coagulation Factor VIIa Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor VIIa Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor VIIa Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Coagulation Factor VIIa market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor VIIa is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Coagulation Factor VIIa market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Coagulation Factor VIIa market include Novo Nordisk, LFB SA HEMA Biologics, GENERIUM and AryoGen Pharmed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coagulation Factor VIIa market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coagulation Factor VIIa and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coagulation Factor VIIa sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coagulation Factor VIIa market size, projected growth trends, production technologies, key applications, and end-use industries.

Coagulation Factor VIIa Segment by Company

Novo Nordisk

LFB SA HEMA Biologics

GENERIUM

AryoGen Pharmed

Coagulation Factor VIIa Segment by Type

Prefilled Syringe

Vial

Coagulation Factor VIIa Segment by Application

Congenital Hemophilia

Acquired Hemophilia

Other

Coagulation Factor VIIa Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Coagulation Factor VIIa status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Coagulation Factor VIIa market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coagulation Factor VIIa significant trends, drivers, influence factors in global and regions.

6. To analyze Coagulation Factor VIIa competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor VIIa market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor VIIa and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor VIIa.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coagulation Factor VIIa market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coagulation Factor VIIa industry.

Chapter 3: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Coagulation Factor VIIa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Coagulation Factor VIIa in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coagulation Factor VIIa Industry Trends Table 2. Coagulation Factor VIIa Industry Drivers Table 3. Coagulation Factor VIIa Industry Opportunities and Challenges Table 4. Coagulation Factor VIIa Industry Restraints Table 5. Global Coagulation Factor VIIa Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coagulation Factor VIIa Revenue Share by Company (2021-2026) Table 7. Global Coagulation Factor VIIa Sales Volume by Company (tons) & (2021-2026) Table 8. Global Coagulation Factor VIIa Sales Volume Share by Company (2021-2026) Table 9. Global Coagulation Factor VIIa Average Price (US$/kg) of Company (2021-2026) Table 10. Global Coagulation Factor VIIa Company Ranking, (2024-2026) & (USD Million) Table 11. Global Coagulation Factor VIIa Key Company Manufacturing Base & Headquarters Table 12. Global Coagulation Factor VIIa Company, Product Type & Application Table 13. Global Coagulation Factor VIIa Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Coagulation Factor VIIa by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Prefilled Syringe Table 18. Significant Companies of Vial Table 19. Global Coagulation Factor VIIa Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Coagulation Factor VIIa Sales Volume by Type (2021-2026) & (tons) Table 21. Global Coagulation Factor VIIa Sales Volume by Type (2027-2032) & (tons) Table 22. Global Coagulation Factor VIIa Sales Volume Share by Type (2021-2026) Table 23. Global Coagulation Factor VIIa Sales Volume Share by Type (2027-2032) Table 24. Global Coagulation Factor VIIa Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Coagulation Factor VIIa Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Coagulation Factor VIIa Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Coagulation Factor VIIa Sales Value Share by Type (2021-2026) Table 28. Global Coagulation Factor VIIa Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Congenital Hemophilia Table 30. Significant Companies of Acquired Hemophilia Table 31. Significant Companies of Other Table 32. Global Coagulation Factor VIIa Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 33. Global Coagulation Factor VIIa Sales Volume by Application (2021-2026) & (tons) Table 34. Global Coagulation Factor VIIa Sales Volume by Application (2027-2032) & (tons) Table 35. Global Coagulation Factor VIIa Sales Volume Share by Application (2021-2026) Table 36. Global Coagulation Factor VIIa Sales Volume Share by Application (2027-2032) Table 37. Global Coagulation Factor VIIa Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Coagulation Factor VIIa Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Coagulation Factor VIIa Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Coagulation Factor VIIa Sales Value Share by Application (2021-2026) Table 41. Global Coagulation Factor VIIa Sales Value Share by Application (2027-2032) Table 42. Global Coagulation Factor VIIa Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 43. Global Coagulation Factor VIIa Sales by Region (2021-2026) & (tons) Table 44. Global Coagulation Factor VIIa Sales Market Share by Region (2021-2026) Table 45. Global Coagulation Factor VIIa Sales by Region (2027-2032) & (tons) Table 46. Global Coagulation Factor VIIa Sales Market Share by Region (2027-2032) Table 47. Global Coagulation Factor VIIa Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Coagulation Factor VIIa Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Coagulation Factor VIIa Sales Value Share by Region (2021-2026) Table 50. Global Coagulation Factor VIIa Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Coagulation Factor VIIa Sales Value Share by Region (2027-2032) Table 52. Global Coagulation Factor VIIa Market Average Price (US$/kg) by Region (2021-2026) Table 53. Global Coagulation Factor VIIa Market Average Price (US$/kg) by Region (2027-2032) Table 54. Global Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 55. Global Coagulation Factor VIIa Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Coagulation Factor VIIa Sales by Country (2021-2026) & (tons) Table 57. Global Coagulation Factor VIIa Sales Market Share by Country (2021-2026) Table 58. Global Coagulation Factor VIIa Sales by Country (2027-2032) & (tons) Table 59. Global Coagulation Factor VIIa Sales Market Share by Country (2027-2032) Table 60. Global Coagulation Factor VIIa Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Coagulation Factor VIIa Sales Value Market Share by Country (2021-2026) Table 62. Global Coagulation Factor VIIa Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Coagulation Factor VIIa Sales Value Market Share by Country (2027-2032) Table 64. Novo Nordisk Company Information Table 65. Novo Nordisk Business Overview Table 66. Novo Nordisk Coagulation Factor VIIa Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Novo Nordisk Coagulation Factor VIIa Product Portfolio Table 68. Novo Nordisk Recent Development Table 69. LFB SA HEMA Biologics Company Information Table 70. LFB SA HEMA Biologics Business Overview Table 71. LFB SA HEMA Biologics Coagulation Factor VIIa Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio Table 73. LFB SA HEMA Biologics Recent Development Table 74. GENERIUM Company Information Table 75. GENERIUM Business Overview Table 76. GENERIUM Coagulation Factor VIIa Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. GENERIUM Coagulation Factor VIIa Product Portfolio Table 78. GENERIUM Recent Development Table 79. AryoGen Pharmed Company Information Table 80. AryoGen Pharmed Business Overview Table 81. AryoGen Pharmed Coagulation Factor VIIa Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. AryoGen Pharmed Coagulation Factor VIIa Product Portfolio Table 83. AryoGen Pharmed Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Coagulation Factor VIIa Distributors List Table 87. Coagulation Factor VIIa Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Coagulation Factor VIIa Product Image Figure 2. Global Coagulation Factor VIIa Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor VIIa Sales Value (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor VIIa Sales (2021-2032) & (tons) Figure 5. Global Coagulation Factor VIIa Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Coagulation Factor VIIa Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Prefilled Syringe Image Figure 10. Vial Image Figure 11. Global Coagulation Factor VIIa Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Coagulation Factor VIIa Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Coagulation Factor VIIa Sales Volume Share by Type (2021-2032) Figure 14. Global Coagulation Factor VIIa Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Coagulation Factor VIIa Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Coagulation Factor VIIa Sales Value Share by Type (2021-2032) Figure 17. Congenital Hemophilia Image Figure 18. Acquired Hemophilia Image Figure 19. Other Image Figure 20. Global Coagulation Factor VIIa Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 21. Global Coagulation Factor VIIa Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Coagulation Factor VIIa Sales Volume Share by Application (2021-2032) Figure 23. Global Coagulation Factor VIIa Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Coagulation Factor VIIa Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Coagulation Factor VIIa Sales Value Share by Application (2021-2032) Figure 26. Global Coagulation Factor VIIa Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 27. Global Coagulation Factor VIIa Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Coagulation Factor VIIa Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Coagulation Factor VIIa Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Coagulation Factor VIIa Sales Value (2021-2032) & (US$ Million) Figure 31. North America Coagulation Factor VIIa Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Coagulation Factor VIIa Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Coagulation Factor VIIa Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Coagulation Factor VIIa Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Coagulation Factor VIIa Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Coagulation Factor VIIa Sales Value (2021-2032) & (US$ Million) Figure 37. South America Coagulation Factor VIIa Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Coagulation Factor VIIa Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Coagulation Factor VIIa Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Coagulation Factor VIIa Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Coagulation Factor VIIa Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Coagulation Factor VIIa Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Prefilled Syringe
  • Vial
Applications
  • Congenital Hemophilia
  • Acquired Hemophilia
  • Other
Companies covered
  • Novo Nordisk
  • LFB SA HEMA Biologics
  • GENERIUM
  • AryoGen Pharmed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coagulation Factor VIIa Sales Value (2021-2032)
  4. 1.2.2 Global Coagulation Factor VIIa Sales Volume (2021-2032)
  5. 1.2.3 Global Coagulation Factor VIIa Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Coagulation Factor VIIa Market Dynamics
  1. 2.1 Coagulation Factor VIIa Industry Trends
  2. 2.2 Coagulation Factor VIIa Industry Drivers
  3. 2.3 Coagulation Factor VIIa Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor VIIa Industry Restraints
3 Coagulation Factor VIIa Market by Company
  1. 3.1 Global Coagulation Factor VIIa Company Revenue Ranking in 2025
  2. 3.2 Global Coagulation Factor VIIa Revenue by Company (2021-2026)
  3. 3.3 Global Coagulation Factor VIIa Sales Volume by Company (2021-2026)
  4. 3.4 Global Coagulation Factor VIIa Average Price by Company (2021-2026)
  5. 3.5 Global Coagulation Factor VIIa Company Ranking (2024-2026)
  6. 3.6 Global Coagulation Factor VIIa Company Manufacturing Base and Headquarters
  7. 3.7 Global Coagulation Factor VIIa Company Product Type and Application
  8. 3.8 Global Coagulation Factor VIIa Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Coagulation Factor VIIa Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Coagulation Factor VIIa Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Coagulation Factor VIIa Market by Type
  1. 4.1 Coagulation Factor VIIa Type Introduction
  2. 4.1.1 Prefilled Syringe
  3. 4.1.2 Vial
  4. 4.2 Global Coagulation Factor VIIa Sales Volume by Type
  5. 4.2.1 Global Coagulation Factor VIIa Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coagulation Factor VIIa Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Coagulation Factor VIIa Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Coagulation Factor VIIa Sales Value by Type
  9. 4.3.1 Global Coagulation Factor VIIa Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coagulation Factor VIIa Sales Value by Type (2021-2032)
  11. 4.3.3 Global Coagulation Factor VIIa Sales Value Share by Type (2021-2032)
5 Coagulation Factor VIIa Market by Application
  1. 5.1 Coagulation Factor VIIa Application Introduction
  2. 5.1.1 Congenital Hemophilia
  3. 5.1.2 Acquired Hemophilia
  4. 5.1.3 Other
  5. 5.2 Global Coagulation Factor VIIa Sales Volume by Application
  6. 5.2.1 Global Coagulation Factor VIIa Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coagulation Factor VIIa Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Coagulation Factor VIIa Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Coagulation Factor VIIa Sales Value by Application
  10. 5.3.1 Global Coagulation Factor VIIa Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Coagulation Factor VIIa Sales Value by Application (2021-2032)
  12. 5.3.3 Global Coagulation Factor VIIa Sales Value Share by Application (2021-2032)
6 Coagulation Factor VIIa Regional Sales and Value Analysis
  1. 6.1 Global Coagulation Factor VIIa Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coagulation Factor VIIa Sales by Region (2021-2032)
  3. 6.2.1 Global Coagulation Factor VIIa Sales by Region: 2021-2026
  4. 6.2.2 Global Coagulation Factor VIIa Sales by Region (2027-2032)
  5. 6.3 Global Coagulation Factor VIIa Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Coagulation Factor VIIa Sales Value by Region (2021-2032)
  7. 6.4.1 Global Coagulation Factor VIIa Sales Value by Region: 2021-2026
  8. 6.4.2 Global Coagulation Factor VIIa Sales Value by Region (2027-2032)
  9. 6.5 Global Coagulation Factor VIIa Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Coagulation Factor VIIa Sales Value (2021-2032)
  12. 6.6.2 North America Coagulation Factor VIIa Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Coagulation Factor VIIa Sales Value (2021-2032)
  15. 6.7.2 Europe Coagulation Factor VIIa Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Coagulation Factor VIIa Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Coagulation Factor VIIa Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Coagulation Factor VIIa Sales Value (2021-2032)
  21. 6.9.2 South America Coagulation Factor VIIa Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Coagulation Factor VIIa Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Coagulation Factor VIIa Sales Value Share by Country, 2025 VS 2032
7 Coagulation Factor VIIa Country-level Sales and Value Analysis
  1. 7.1 Global Coagulation Factor VIIa Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coagulation Factor VIIa Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Coagulation Factor VIIa Sales by Country (2021-2032)
  4. 7.3.1 Global Coagulation Factor VIIa Sales by Country (2021-2026)
  5. 7.3.2 Global Coagulation Factor VIIa Sales by Country (2027-2032)
  6. 7.4 Global Coagulation Factor VIIa Sales Value by Country (2021-2032)
  7. 7.4.1 Global Coagulation Factor VIIa Sales Value by Country (2021-2026)
  8. 7.4.2 Global Coagulation Factor VIIa Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Coagulation Factor VIIa Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Coagulation Factor VIIa Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Coagulation Factor VIIa Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Coagulation Factor VIIa Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 LFB SA HEMA Biologics
  8. 8.2.1 LFB SA HEMA Biologics Company Information
  9. 8.2.2 LFB SA HEMA Biologics Business Overview
  10. 8.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Product Portfolio
  12. 8.2.5 LFB SA HEMA Biologics Recent Developments
  13. 8.3 GENERIUM
  14. 8.3.1 GENERIUM Company Information
  15. 8.3.2 GENERIUM Business Overview
  16. 8.3.3 GENERIUM Coagulation Factor VIIa Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GENERIUM Coagulation Factor VIIa Product Portfolio
  18. 8.3.5 GENERIUM Recent Developments
  19. 8.4 AryoGen Pharmed
  20. 8.4.1 AryoGen Pharmed Company Information
  21. 8.4.2 AryoGen Pharmed Business Overview
  22. 8.4.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AryoGen Pharmed Coagulation Factor VIIa Product Portfolio
  24. 8.4.5 AryoGen Pharmed Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coagulation Factor VIIa Value Chain Analysis
  2. 9.1.1 Coagulation Factor VIIa Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coagulation Factor VIIa Sales Mode & Process
  6. 9.2 Coagulation Factor VIIa Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coagulation Factor VIIa Distributors
  9. 9.2.3 Coagulation Factor VIIa Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst